{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:18:26Z","timestamp":1793902706622,"version":"4.8.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK116042"],"award-info":[{"award-number":["U01DK116042"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010390","name":"Saint Louis University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022885","name":"PKD Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.semnephrol.2025.151658","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T11:15:23Z","timestamp":1752750923000},"page":"151658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Utility of Genetic Information for Management in Kidney Transplantation and Living Donation"],"prefix":"10.1016","volume":"45","author":[{"given":"Yasar","family":"Caliskan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.semnephrol.2025.151658_bib0001","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151658_bib0002","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1093\/ndt\/17.12.2212","article-title":"Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001","volume":"17","author":"McDonald","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151658_bib0003","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/ndt\/gfae105","article-title":"Time trends in preemptive kidney transplantation in Europe: an ERA registry study","volume":"39","author":"Kramer","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"2S1","key":"10.1016\/j.semnephrol.2025.151658_bib0004","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ajt.2024.01.012","article-title":"OPTN\/SRTR 2022 annual data report: kidney","volume":"24","author":"Lentine","year":"2024","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncpneph0383","article-title":"Living donor renal transplantation: recent developments and perspectives","volume":"3","author":"Baid-Agrawal","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"issue":"9981","key":"10.1016\/j.semnephrol.2025.151658_bib0006","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0140-6736(14)62484-3","article-title":"Living kidney donation: outcomes, ethics, and uncertainty","volume":"385","author":"Reese","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151658_bib0007","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1681\/ASN.2016101084","article-title":"Quantifying postdonation risk of ESRD in living kidney donors","volume":"28","author":"Massie","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0008","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.14678","article-title":"Risk of ESRD in prior living kidney donors","volume":"18","author":"Wainright","year":"2018","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0009","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0272-6386(99)70435-X","article-title":"Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation","volume":"33","author":"Winn","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2025.151658_bib0010","first-page":"1","article-title":"Female with Fabry disease unknowingly donates affected kidney to sister: a call for pre-transplant genetic testing","volume":"4","author":"Paull","year":"2012","journal-title":"JIMD Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0011","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0012","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfab218","article-title":"Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice","volume":"37","author":"Knoers","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0013","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13023-021-02013-x","article-title":"The frequency of rare and monogenic diseases in pediatric organ transplant recipients in Italy","volume":"16","author":"Vaisitti","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0014","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1681\/ASN.2018060575","article-title":"Whole-exome sequencing enables a precision medicine approach for kidney transplant recipients","volume":"30","author":"Mann","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151658_bib0015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41436-021-01127-8","article-title":"The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation","volume":"23","author":"Schrezenmeier","year":"2021","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0016","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.kint.2019.01.038","article-title":"Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease","volume":"96","author":"Ottlewski","year":"2019","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151658_bib0017","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2215\/CJN.00280121","article-title":"Recurrent glomerular disease after kidney transplantation: diagnostic and management dilemmas","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0018","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/TP.0000000000004363","article-title":"Incorporation of genetic studies in the kidney transplant evaluation clinic: the value of a multidisciplinary approach","volume":"107","author":"El Ters","year":"2023","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pd.4487","article-title":"Consanguinity and pregnancy outcomes in a multi-ethnic, metropolitan European population","volume":"35","author":"Becker","year":"2015","journal-title":"Prenat Diagn"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajt.2023.02.020","article-title":"Genetic evaluation of living kidney donor candidates: a review and recommendations for best practices","volume":"23","author":"Thomas","year":"2023","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0021","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajt.2024.10.019","article-title":"Evaluation for genetic disease in kidney transplant candidates: a practice resource","volume":"25","author":"Ames","year":"2025","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0022","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s40620-023-01588-x","article-title":"Propensity score-matched analysis of long-term outcomes for living kidney donation in alternative complement pathway diseases: a pilot study","volume":"36","author":"Caliskan","year":"2023","journal-title":"J Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151658_bib0023","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ajt.2023.05.006","article-title":"Pediatric combined living donor liver and kidney transplantation for primary hyperoxaluria type 2","volume":"23","author":"Hosaagrahara Ramakrishna","year":"2023","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0024","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1038\/s41598-024-57273-x","article-title":"People with genetic kidney diseases on kidney replacement therapy have different clinical outcomes compared to people with other kidney diseases","volume":"14","author":"Han","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajt.2024.10.019","article-title":"Evaluation for genetic disease in kidney transplant candidates: a practice resource","volume":"25","author":"Ames","year":"2025","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0026","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0027","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0028","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/TP.0000000000004355","article-title":"Assessing the impact of prophylactic eculizumab on renal graft survival in atypical hemolytic uremic syndrome","volume":"107","author":"Glover","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2025.151658_bib0029","article-title":"CFH and CFHR structural variants in atypical hemolytic uremic syndrome: prevalence, genomic characterization and impact on outcome","volume":"13","author":"Piras","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151658_bib0030","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00467-010-1446-9","article-title":"DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome","volume":"25","author":"Zipfel","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0031","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-200202150-00013","article-title":"Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin","volume":"73","author":"Patrakka","year":"2002","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0032","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ekir.2024.01.005","article-title":"Steroid-resistant nephrotic syndrome due to NPHS2 variants is not associated with posttransplant recurrence","volume":"9","author":"Kachmar","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0033","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2010010029","article-title":"Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation","volume":"22","author":"Jungraithmayr","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151658_bib0034","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0035","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1542\/peds.2006-2164","article-title":"Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)","volume":"119","author":"Hinkes","year":"2007","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0036","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2215\/CJN.08750718","article-title":"Integration of genetic testing and pathology for the diagnosis of adults with FSGS","volume":"14","author":"Yao","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151658_bib0037","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-019-04282-y","article-title":"Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis","volume":"35","author":"Demir","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"1-2","key":"10.1016\/j.semnephrol.2025.151658_bib0038","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-5793(90)80510-P","article-title":"Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene","volume":"276","author":"Maury","year":"1990","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151658_bib0039","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/TP.0000000000003170","article-title":"Kidney transplantation in systemic amyloidosis","volume":"104","author":"Angel-Korman","year":"2020","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2024.01.527","article-title":"Hereditary transthyretin amyloidosis and the impact of classic and new treatments on kidney function: a review","volume":"84","author":"Melendrez-Balcazar","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151658_bib0041","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1007\/s00467-024-06328-2","article-title":"Diagnosis and management of primary hyperoxalurias: best practices","volume":"39","author":"Michael","year":"2024","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151658_bib0042","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJMc2312941","article-title":"Lumasiran, isolated kidney transplantation, and continued vigilance","volume":"390","author":"Bacchetta","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151658_bib0043","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ekir.2023.03.013","article-title":"Successful treatment of primary hyperoxaluria type 2 with a combined liver and kidney transplant","volume":"8","author":"Genena","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151658_bib0044","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2215\/CJN.01330214","article-title":"Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy","volume":"9","author":"Freedman","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151658_bib0045","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.0000000000000219","article-title":"Genetic inhibition of APOL1 pore-forming function prevents APOL1-mediated kidney disease","volume":"34","author":"Hung","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0046","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1038\/s41467-023-43020-9","article-title":"Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease","volume":"14","author":"Gupta","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151658_bib0047","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1111\/tri.14133","article-title":"Sequential genetic testing of living-related donors for inherited renal disease to promote informed choice and enhance safety of living donation","volume":"34","author":"Thomas","year":"2021","journal-title":"Transpl Int"},{"issue":"4S","key":"10.1016\/j.semnephrol.2025.151658_bib0048","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/genes13040592","article-title":"Vignette-based reflections to inform genetic testing policies in living kidney donors","volume":"13","author":"Singh","year":"2022","journal-title":"Genes (Basel)"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151658_bib0050","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151658_bib0051","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1053\/j.ajkd.2018.07.017","article-title":"African American living donors' attitudes about APOL1 genetic testing: a mixed methods study","volume":"72","author":"Gordon","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0052","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/ajt.16206","article-title":"Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation","volume":"21","author":"Berrigan","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151658_bib0053","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1097\/TP.0000000000003641","article-title":"Integrating APOL1 kidney-risk variant testing in live kidney donor evaluation: an expert panel opinion","volume":"105","author":"Doshi","year":"2021","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0054","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1526924818817048","article-title":"A national survey of transplant surgeons and nephrologists on implementing apolipoprotein l1 (APOL1) genetic testing into clinical practice","volume":"29","author":"Gordon","year":"2019","journal-title":"Prog Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151658_bib0055","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/ajt.13788","article-title":"Long-term clinical impact of adaptation of initial tacrolimus dosing to CYP3A5 genotype","volume":"16","author":"Pallet","year":"2016","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151658_bib0056","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrneph.2011.74","article-title":"Azathioprine-related myelosuppression in a patient homozygous for TPMT*3A","volume":"7","author":"Budhiraja","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151658_bib0057","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrneph.2014.172","article-title":"Pharmacogenetics and immunosuppressive drugs in solid organ transplantation","volume":"10","author":"van Gelder","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0058","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ajt.14504","article-title":"Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation","volume":"18","author":"Davis","year":"2018","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151658_bib0059","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/tri.12155","article-title":"Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF genomics","volume":"26","author":"Israni","year":"2013","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"7809","key":"10.1016\/j.semnephrol.2025.151658_bib0061","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2025.151658_bib0062","unstructured":"Genome Aggregation Database (gnomAD). gnomAD v4.0. Broad Institute. Accessed February 7, 2025. https:\/\/gnomad.broadinstitute.org\/"},{"issue":"46","key":"10.1016\/j.semnephrol.2025.151658_bib0063","doi-asserted-by":"crossref","first-page":"81285","DOI":"10.18632\/oncotarget.18150","article-title":"Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0064","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/FPC.0000000000000494","article-title":"Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation","volume":"33","author":"Rao","year":"2023","journal-title":"Pharmacogenet Genomics"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151658_bib0065","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/jcph.2249","article-title":"Implementation of clinical cytochrome P450 3A genotyping for tacrolimus dosing in a large kidney transplant program","volume":"63","author":"Tillman","year":"2023","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0066","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13494","article-title":"CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients","volume":"23","author":"Yanik","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"19","key":"10.1016\/j.semnephrol.2025.151658_bib0067","article-title":"Early CYP3A5 genotype-based adjustment of tacrolimus dosage reduces risk of de novo donor-specific HLA antibodies and rejection among CYP3A5-expressing renal transplant patients","volume":"14","author":"Schonfelder","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151658_bib0068","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13285","article-title":"A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation","volume":"22","author":"Min","year":"2018","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0069","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2125.2001.01371.x","article-title":"Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus","volume":"51","author":"Kubota","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2010.320","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0071","article-title":"The value of pharmacogenomics for white and indigenous americans after kidney transplantation","volume":"11","author":"Brady","year":"2023","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.semnephrol.2025.151658_bib0072","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2018.00321","article-title":"PIRCHE-II is related to graft failure after kidney transplantation","volume":"9","author":"Geneugelijk","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151658_bib0073","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165426","article-title":"Comparison of HLA-A, -B and -DRB1 loci polymorphism between kidney transplants of uremia patients and healthy individuals in central China","volume":"11","author":"Shang","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0074","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24251","article-title":"Association of end-stage renal disease with HLA phenotypes and panel reactive antibodies in patients awaiting renal transplantation in Hunan Province","volume":"36","author":"Long","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151658_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102741","article-title":"Donor-derived cell-free DNA at 1 month after kidney transplantation relates to HLA class II eplet mismatch load","volume":"11","author":"Gonzalez-Lopez","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151658_bib0077","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/petr.12762","article-title":"Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: a new histocompatibility paradigm","volume":"20","author":"Bryan","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0078","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s42003-021-01989-3","article-title":"High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation","volume":"4","author":"Tran","year":"2021","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0079","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.12968","article-title":"HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study","volume":"15","author":"Sapir-Pichhadze","year":"2015","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151658_bib0080","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.12478","article-title":"Class II HLA epitope matching: a strategy to minimize de novo donor-specific antibody development and improve outcomes","volume":"13","author":"Wiebe","year":"2013","journal-title":"Am J Transplant"},{"issue":"17","key":"10.1016\/j.semnephrol.2025.151658_bib0081","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.18632\/oncotarget.24349","article-title":"Correlation and agreement between eplet mismatches calculated using serological, low-intermediate and high resolution molecular human leukocyte antigen typing methods","volume":"9","author":"Fidler","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151658_bib0082","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/TXD.0000000000000632","article-title":"The association between broad antigen HLA mismatches, eplet HLA mismatches and acute rejection after kidney transplantation","volume":"2","author":"Do Nguyen","year":"2016","journal-title":"Transplant Direct"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0083","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ctr.12663","article-title":"Sensitization trends after renal allograft failure: the role of DQ eplet mismatches in becoming highly sensitized","volume":"30","author":"Singh","year":"2016","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0084","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13508","article-title":"Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: antigenic, allelic, epitope, or physiochemical HLA mismatches?","volume":"33","author":"Delion","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2025.151658_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.832488","article-title":"Improving access to HLA-matched kidney transplants for African American patients","volume":"13","author":"Bekbolsynov","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0086","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2017060658","article-title":"APOL1 genotype and renal function of Black living donors","volume":"29","author":"Doshi","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"10.1016\/j.semnephrol.2025.151658_bib0087","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1803731","article-title":"Genomic mismatch at LIMS1 locus and kidney allograft rejection","volume":"380","author":"Steers","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151658_bib0088","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/ndt\/gfab168","article-title":"LIMS1 risk genotype and T cell-mediated rejection in kidney transplant recipients","volume":"36","author":"Caliskan","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0089","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.kint.2024.07.027","article-title":"Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)","volume":"106","author":"Goutaudier","year":"2024","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151658_bib0090","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/ajt.14594","article-title":"Long- and short-term outcomes in renal allografts with deceased donors: a large recipient and donor genome-wide association study","volume":"18","author":"Hernandez-Fuentes","year":"2018","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0091","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ctr.12093","article-title":"A genome-wide association study of recipient genotype and medium-term kidney allograft function","volume":"27","author":"O'Brien","year":"2013","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0092","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/ajt.13995","article-title":"Single nucleotide polymorphisms and long-term clinical outcome in renal transplant patients: a validation study","volume":"17","author":"Pihlstrom","year":"2017","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0093","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1681\/ASN.2013040383","article-title":"Genetics of new-onset diabetes after transplantation","volume":"25","author":"McCaughan","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0094","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ndt\/gfp782","article-title":"Genetic predictors of acute renal transplant rejection","volume":"25","author":"Goldfarb-Rumyantzev","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"10174","key":"10.1016\/j.semnephrol.2025.151658_bib0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0140-6736(18)32473-5","article-title":"Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort","volume":"393","author":"Reindl-Schwaighofer","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0096","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41591-022-01758-7","article-title":"Donor and recipient polygenic risk scores influence the risk of post-transplant diabetes","volume":"28","author":"Shaked","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151658_bib0097","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MOT.0000000000000718","article-title":"Genetic background and transplantation outcomes: insights from genome-wide association studies","volume":"25","author":"Zanoni","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151658_bib0098","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/ajt.15057","article-title":"Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort","volume":"19","author":"Stapleton","year":"2019","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151658_bib0099","doi-asserted-by":"crossref","first-page":"325-333 e6","DOI":"10.1016\/j.jid.2020.06.017","article-title":"Polygenic risk scores allow risk stratification for keratinocyte cancer in organ-transplant recipients","volume":"141","author":"Seviiri","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303446","article-title":"Polygenic risk score for acute rejection based on donor-recipient non-HLA genotype mismatch","volume":"19","author":"Cao","year":"2024","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151658_bib0101","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bjo.71.6.405","article-title":"Cataract: the relation between myopia and cataract morphology","volume":"71","author":"Brown","year":"1987","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0102","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067657","article-title":"Implementation of a culturally competent APOL1 genetic testing programme into living donor evaluation: a two-site, non-randomised, pre-post trial design","volume":"13","author":"Smith","year":"2023","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151658_bib0103","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.16930","article-title":"First clinical-grade porcine kidney xenotransplant using a human decedent model","volume":"22","author":"Porrett","year":"2022","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151658_bib0104","doi-asserted-by":"crossref","first-page":"lnae037","DOI":"10.1093\/lifemedi\/lnae037","article-title":"Xenotransplantation: how close are we to clinical applications?","volume":"3","author":"Zhang","year":"2024","journal-title":"Life Med"},{"key":"10.1016\/j.semnephrol.2025.151658_bib0105","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fgene.2019.01084","article-title":"Genome-wide study updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN)","volume":"10","author":"Fishman","year":"2019","journal-title":"Front Genet"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T05:44:54Z","timestamp":1762753494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929525000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0270929525000968"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151658","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Genetic Information for Management in Kidney Transplantation and Living Donation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"151658"}}